Teriparatide (Human Parathyroid Hormone (1-34)) Inhibits Osteogenic Vascular Calcification in Diabetic Low Density Lipoprotein Receptor-deficient Mice

Medicine & Life Sciences

• Teriparatide 67%
• Vascular Calcification 61%
• LDL Receptors 55%
• Osteopontin 50%
• Parathyroid Hormone 47%
• Myofibroblasts 12%
• Serum 7%
• Osteoprotegerin 6%
• Lipid Droplets 6%
• Heart Valves 5%
• High Fat Diet 5%
• Leptin 5%
• Dyslipidemias 5%
• Bone Density 4%
• Reverse Transcription 4%
• Osteogenesis 4%
• Aorta 4%
• Adipose Tissue 4%
• Fluorescence 4%
• X-Rays 4%
• Extremities 3%
• Body Weight 3%
• RNA 3%
• Diet 3%
• Staining and Labeling 3%
• Glucose 3%
• Gene Expression 3%
• Polymerase Chain Reaction 3%
• In Vitro Techniques 2%

Chemical Compounds

• Teriparatide 100%
• Parathyroid Hormone 68%
• Osteogenic 60%
• Valve 15%
• Fat 9%
• Diabetogenic 8%
• Leptin 8%
• Glucose 3%
• Lipid 3%
• Fluorescence 2%
• Weight 2%
• Energy 2%
• Time 1%